Charles S Peretti1, Fabien Gierski, Sophie Harrois. 1. Service de Psychiatrie des Adultes, Hôpital Robert Debré, CHU de Reims, Avenue du Général Koenig, 51092, Reims Cedex, France. cperetti@chu-reims.fr
Abstract
RATIONALE: Cognitive skill learning, as assessed by repeated testing on the Tower of Toronto (TT) task, has been found to be impaired in normal aging. There is evidence that this impairment might be accounted for by the well-documented, age-dependent decline of dopamine D2-like receptor availability. OBJECTIVES: This study was an investigation of whether the D2/D3 dopaminergic agonist piribedil improves cognitive skill learning in older adults. METHODS:Healthy elderly volunteers were assessed using the TT paradigm. Subjects were evaluated at baseline, and after 2 months of a placebo or piribedil (50 mg daily) treatment in a double-blind, crossover design. Two components of cognitive skill learning were considered--the ability to learn to solve the puzzle and the acquisition of a problem-solving routine. RESULTS:Piribedil showed a beneficial effect on the acquisition of a problem-solving routine, depending on the age of subjects, as revealed by solution reliability indexes measures. The effect of piribedil on the ability to learn to solve the puzzle was found to be dependent on the subject's working memory capacities. CONCLUSIONS: The present results suggest that piribedil is likely to enhance cognitive skill learning in healthy older adults and give further evidence that age-related dopamine decline plays an important role in cognitive impairment occurring in normal aging.
RCT Entities:
RATIONALE: Cognitive skill learning, as assessed by repeated testing on the Tower of Toronto (TT) task, has been found to be impaired in normal aging. There is evidence that this impairment might be accounted for by the well-documented, age-dependent decline of dopamine D2-like receptor availability. OBJECTIVES: This study was an investigation of whether the D2/D3 dopaminergic agonist piribedil improves cognitive skill learning in older adults. METHODS: Healthy elderly volunteers were assessed using the TT paradigm. Subjects were evaluated at baseline, and after 2 months of a placebo or piribedil (50 mg daily) treatment in a double-blind, crossover design. Two components of cognitive skill learning were considered--the ability to learn to solve the puzzle and the acquisition of a problem-solving routine. RESULTS:Piribedil showed a beneficial effect on the acquisition of a problem-solving routine, depending on the age of subjects, as revealed by solution reliability indexes measures. The effect of piribedil on the ability to learn to solve the puzzle was found to be dependent on the subject's working memory capacities. CONCLUSIONS: The present results suggest that piribedil is likely to enhance cognitive skill learning in healthy older adults and give further evidence that age-related dopamine decline plays an important role in cognitive impairment occurring in normal aging.
Authors: N D Volkow; J Logan; J S Fowler; G J Wang; R C Gur; C Wong; C Felder; S J Gatley; Y S Ding; R Hitzemann; N Pappas Journal: Am J Psychiatry Date: 2000-01 Impact factor: 18.112
Authors: C S Peretti; J M Danion; F Kauffmann-Muller; D Grangé; A Patat; P Rosenzweig Journal: Psychopharmacology (Berl) Date: 1997-06 Impact factor: 4.530
Authors: N D Volkow; Y S Ding; J S Fowler; G J Wang; J Logan; S J Gatley; R Hitzemann; G Smith; S D Fields; R Gur Journal: J Nucl Med Date: 1996-04 Impact factor: 10.057
Authors: N D Volkow; R C Gur; G J Wang; J S Fowler; P J Moberg; Y S Ding; R Hitzemann; G Smith; J Logan Journal: Am J Psychiatry Date: 1998-03 Impact factor: 18.112
Authors: Rachael D Seidler; Jessica A Bernard; Taritonye B Burutolu; Brett W Fling; Mark T Gordon; Joseph T Gwin; Youngbin Kwak; David B Lipps Journal: Neurosci Biobehav Rev Date: 2009-10-20 Impact factor: 8.989
Authors: Alexa M Morcom; Edward T Bullmore; Felicia A Huppert; Belinda Lennox; Asha Praseedom; Helen Linnington; Paul C Fletcher Journal: Cereb Cortex Date: 2009-07-22 Impact factor: 5.357